Vericel Scheduled to Report Q3 2026 Earnings Results
Vericel Corporation (VCEL) is set to release its third-quarter 2026 financial results on Thursday, November 5th, prior to the market opening. Market analysts are projecting a revenue estimate of $77.95 million, representing a year-over-year increase of 15.5%. Despite expected revenue growth, earnings per share (EPS) are forecasted at $0.06, which marks a significant 40% decline compared to the same period last year. Recent analyst sentiment has been cautious, with EPS estimates seeing two downward revisions and zero upward revisions over the past three months.
Tickers: $VCEL
Topics: earnings preview EPS estimates healthcare revenue estimates